Plunkett Research Online: Chemocentryx Inc

CHEMOCENTRYX INC (CCXI:NAS) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Chemocentryx, Inc is a biopharmaceutical company focused on discovering, developing and commercializing orally-administered therapeutics to treat autoimmune diseases, inflammatory disorders and cancer. The company’s approach has been to target the chemokine system, as well as related chemo-attracta.....



Chemocentryx Inc
Ticker: CCXI
Exchange: NAS
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 650 210-2900
Fax: 650 210-2910
Address: 850 Maude Avenue
Mountain View, CA 94043 United States

Types Of Business
Industry Ranks

Industry NAICS code:

Pharmaceutical Preparation Manufacturing
ContactsDescription
Thomas SchallCEO/Chairman of the Board/Director/Founder/President
Susan KanayaCFO/Chief Accounting Officer/Chief Administrative Officer/Executive VP/Secretary
See More
Chemocentryx, Inc is a biopharmaceutical company focused on discovering, developing and commercializing orally-administered therapeutics to treat autoimmune diseases, inflammatory disorders and cancer. The company’s approach has been to target the chemokine system, as well as related chemo-attracta.....See More See More

Auditor: Ernst & Young LLP
Legal Advisor: Latham & Watkins LLP
$USD, In whole numbers,
except marked * or %
201720162015201420132012
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and AffiliatesTop Salaries
NameTitleSalary (US$)Bonus (US$)
Other ThoughtsCorporate Culture

Apparent Female Officers or Directors: